1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Zhejiang Yatai Pharmaceutical Co., Ltd.

Zhejiang Yatai Pharmaceutical Co., Ltd.

002370.SZ
Zhejiang Yatai Pharmaceutical Co., Ltd.CN flagShenzhen Stock Exchange
5.76
CNY
+0.04
- -
4.30BMarket Cap

Total Valuation

Zhejiang Yatai Pharmaceutical Co., Ltd. carries a market capitalization of 4.30B, placing it among publicly traded companies globally. Its enterprise value stands at 2.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.30B
Enterprise Value2.20B

Share Statistics

Zhejiang Yatai Pharmaceutical Co., Ltd. currently has 745.67M shares outstanding.

Shares Outstanding745.67M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Zhejiang Yatai Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 21.08. The price-to-sales ratio is 8.42, and the price-to-book ratio stands at -3.02.

PE Ratio21.08
PS Ratio8.42
PB Ratio-3.02
P/TBV Ratio2.64
P/FCF Ratio413.40
P/OCF RatioN/A

Enterprise Valuation

EV / Sales6.56
EV / EBITDAN/A
EV / EBITN/A
EV / FCF40.86

Financial Position

Zhejiang Yatai Pharmaceutical Co., Ltd. maintains a current ratio of 8.39, meaning it holds 8.4x the short-term assets needed to cover near-term liabilities.

Current Ratio8.39
Quick Ratio6.27
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage-0.39

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)10.26
Return on Invested Capital (ROIC)-1.56
Return on Capital Employed (ROCE)-24.16
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.08

Taxes

Over the trailing twelve months, Zhejiang Yatai Pharmaceutical Co., Ltd. has paid 803,413.60 in income taxes, reflecting an effective tax rate of 0.60.

Income Tax803,413.60
Effective Tax Rate0.60

Stock Price Statistics

Zhejiang Yatai Pharmaceutical Co., Ltd.'s stock has gained approximately 43.6409% over the past 52 weeks. The 50-day moving average sits at 5.95, while the 200-day moving average is 6.88.

Beta (5Y)N/A
52-Week Price Change43.6409%
50-Day Moving Average5.95
200-Day Moving Average6.88
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Zhejiang Yatai Pharmaceutical Co., Ltd. generated 335.32M in revenue and converted that into 133.94M in net income, yielding earnings per share of 0.18. EBITDA reached -18.52M, while operating income came in at -18.52M.

Revenue335.32M
Gross Profit103.76M
Operating Income-18.52M
Pretax Income134.74M
Net Income133.94M
EBITDA-18.52M
EBIT-18.52M
Earnings Per Share (EPS)0.18

Balance Sheet

Total book value stands at -936.42M, with working capital of 737.24M providing operational flexibility.

Cash & Cash Equivalents625.18M
Total DebtN/A
Net Debt-625.18M
Equity (Book Value)-936.42M
Book Value Per Share-1.26
Working Capital737.24M

Cash Flow

After subtracting -6.83M in capital expenditures, free cash flow totaled -6.83M - equivalent to -0.01 per share.

Operating Cash FlowN/A
Capital Expenditures-6.83M
Free Cash Flow-6.83M
FCF Per Share-0.01

Margins

Zhejiang Yatai Pharmaceutical Co., Ltd. operates with a gross margin of 30.94, reflecting its pricing power and cost economics. The operating margin of -5.52 and net profit margin of 39.94 provide insight into operational efficiency.

Gross Margin30.94
Operating Margin-5.52
Pretax Margin40.18
Profit Margin39.94
EBITDA Margin-5.52

Dividends & Yields

The company's payout ratio of 27.90 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.05
Dividend YieldN/A
Payout Ratio27.90
Shareholder Yield10.08
FCF Yield0.24

Stock Splits

Zhejiang Yatai Pharmaceutical Co., Ltd.'s most recent stock split took place on September 20, 2017 with a 1:2 split ratio.

Last Split Date9/20/2017
Split Ratio1:2

Scores

Zhejiang Yatai Pharmaceutical Co., Ltd. posts an Altman Z-Score of 13.91, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score13.91